Cosentyx, a biologic medication, is used to treat various conditions such as psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis [1]. When considering the use of Cosentyx with other medications, it's essential to be aware of potential drug interactions.
According to the Cosentyx website, Cosentyx and other medications should not be co-administered with live vaccines [2]. Additionally, Cosentyx may interact with other biologic medications, such as tumor necrosis factor-alpha (TNF-alpha) inhibitors, which can increase the risk of infections, including tuberculosis and other opportunistic infections.
DrugPatentWatch.com notes that Cosentyx (secukinumab) has 13 patents in its chain [3]. While this list of patents might be relevant for those who wish to research the development and manufacture of Cosentyx, it is not crucial to understanding interactions. Drug interactions can be complex, and it's crucial for patients to inform their healthcare provider about all the medications they are taking to avoid adverse reactions.
A review conducted on the efficacy and safety of Cosentyx in psoriasis treatment highlighted several adverse effects associated with its use, including infections and drug-related reactions [4]. Furthermore, the Cosentyx website provides detailed information on potential interactions and pre-existing conditions, emphasizing the need for healthcare providers to assess individual patient risk factors before prescribing the medication.
For patients taking Cosentyx, it's essential to discuss any new medications or supplements with their healthcare provider and report any adverse effects promptly. Drug interaction monitoring can reduce the risk of adverse reactions and ensure the safe use of Cosentyx.
Sources:
[1] https://www.cosentyx.com/what-is-cosentyx/what-cosentyx-treats/
[2] https://www.cosentyx.com/patient/en-us/side-effects/
[3] https://www.drugpatentwatch.com/patent/US10473651B2/
[4] "Secukinumab in the treatment of psoriasis: a systematic review and meta-analysis." European Journal of Dermatology, vol. 28, no. 5, 2018, pp. 541-554.
[1] https://www.cosentyx.com/what-is-cosentyx/what-cosentyx-treats/
[2] https://www.cosentyx.com/patient/en-us/side-effects/
[3] https://www.drugpatentwatch.com/patent/US10473651B2/
[4] https://pubmed.ncbi.nlm.nih.gov/29914285/